BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32076931)

  • 1. Plasma BNP Levels and Diuretics Use as Predictors of Cardiovascular Events in Patients with Myocardial Infarction and Impaired Glucose Tolerance.
    Shindo K; Fukuda H; Hitsumoto T; Ito S; Kim J; Washio T; Kitakaze M
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):79-88. PubMed ID: 32076931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial Intelligence Uncovered Clinical Factors for Cardiovascular Events in Myocardial Infarction Patients with Glucose Intolerance.
    Shindo K; Fukuda H; Hitsumoto T; Miyashita Y; Kim J; Ito S; Washio T; Kitakaze M
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):535-545. PubMed ID: 32399803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting.
    Ketch TR; Turner SJ; Sacrinty MT; Lingle KC; Applegate RJ; Kutcher MA; Sane DC
    Am Heart J; 2008 Aug; 156(2):234-40. PubMed ID: 18657651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions.
    Cho MS; Ahn JM; Lee CH; Kang DY; Lee JB; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1498-1507. PubMed ID: 28797425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of ST2, IL-33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention.
    Wang YP; Wang JH; Wang XL; Liu JY; Jiang FY; Huang XL; Hang JY; Qin W; Ma SX; Zhang J; Yuan MJ; Li JB; Lu ZG; Wei M
    J Cell Mol Med; 2017 Nov; 21(11):2677-2684. PubMed ID: 28623858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of B-type natriuretic Peptide in patients with unstable angina pectoris or acute myocardial infarction: prognostic significance and therapeutic implications.
    Ahmed W; Zafar S; Alam AY; Ahktar N; Shah MA; Alpert MA
    Angiology; 2007; 58(3):269-74. PubMed ID: 17626979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
    Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired Glucose Tolerance or Newly Diagnosed Diabetes Mellitus Diagnosed during Admission Adversely Affects Prognosis after Myocardial Infarction: An Observational Study.
    George A; Bhatia RT; Buchanan GL; Whiteside A; Moisey RS; Beer SF; Chattopadhyay S; Sathyapalan T; John J
    PLoS One; 2015; 10(11):e0142045. PubMed ID: 26571120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased perioperative b-type natriuretic peptide associates with heart failure hospitalization or heart failure death after coronary artery bypass graft surgery.
    Fox AA; Nascimben L; Body SC; Collard CD; Mitani AA; Liu KY; Muehlschlegel JD; Shernan SK; Marcantonio ER
    Anesthesiology; 2013 Aug; 119(2):284-94. PubMed ID: 23695172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial.
    Ferreira JP; Sharma A; Mehta C; Bakris G; Rossignol P; White WB; Zannad F
    Clin Res Cardiol; 2021 Jul; 110(7):1006-1019. PubMed ID: 32789678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of brain natriuretic peptide after acute myocardial infarction.
    Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal glucose metabolism in acute myocardial infarction: influence on left ventricular function and prognosis.
    Høfsten DE; Løgstrup BB; Møller JE; Pellikka PA; Egstrup K
    JACC Cardiovasc Imaging; 2009 May; 2(5):592-9. PubMed ID: 19442946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Response-to-Diuretic in Predicting Prognosis in Discharged Heart Failure Patients After an Acute Decompensation.
    Feola M; Testa M; Ferreri C; Cardone M; Sola M; Ariotti S; Rosso GL
    Arch Med Res; 2018 Apr; 49(3):198-204. PubMed ID: 30119980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Treatment of Impaired Glucose Tolerance Improve Cardiovascular Outcomes in Patients with Previous Myocardial Infarction?
    Asakura M; Kim J; Asanuma H; Hamasaki T; Tsukahara K; Higashino Y; Ishikawa T; Nakama Y; Koba S; Maruyama Y; Tsujimoto M; Himeno H; Ohkusa T; Fujino S; Shimizu M; Endo T; Yoda S; Muroya T; Murohara T; Ohte N; Suzuki H; Kohno T; Fukui K; Shiono T; Takase H; Uzui H; Nagai Y; Hashimoto Y; Ikeda S; Mizuno S; Tamita K; Fujita M; Satake K; Kinoshita Y; Nunohiro T; Sakagami S; Higaki J; Morii I; Sawada R; Hiasa Y; Shigemasa T; Nakahama M; Sata M; Doi O; Ueda T; Yamada T; Yamanouchi T; Yamaguchi H; Morita Y; Hayashi H; Kitakaze M;
    Cardiovasc Drugs Ther; 2017 Aug; 31(4):401-411. PubMed ID: 28779371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between galectin-3 and clinical parameters in patients with first acute myocardial infarction treated with primary percutaneous coronary angioplasty.
    Szadkowska I; Wlazeł RN; Migała M; Szadkowski K; Zielińska M; Paradowski M; Pawlicki L
    Cardiol J; 2013; 20(6):577-82. PubMed ID: 24338533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of adipokines predict outcome after acute myocardial infarction: A long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.
    Ritsinger V; Brismar K; Malmberg K; Mellbin L; Näsman P; Rydén L; Söderberg S; Tenerz Å; Norhammar A
    Diab Vasc Dis Res; 2017 Mar; 14(2):77-87. PubMed ID: 28185529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
    Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
    Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.